LUCAT1 and chronic obstructive pulmonary disease: Mechanistically, it was suggested that lncRNA-LUCAT1 impaired the anti-inflammatory and anti-apoptotic effects of miR-181-5p in bronchial epithelial cells, thereby contributing to the progression of COPD [34].